About: Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in Italy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in Italy Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in Italy
Creator	Parodi, A Amerio, P Argenziano, G Bardazzi, F Bianchi, L Bongiorno, M Cannav, S Carugno, A Chiricozzi, † Conti, A Dermatologia, Fabbrocini, G Fargnoli, M Feliciani, C Fortina, A Galluzzo, M Gemelli, A Gisondi, P Giustini, S Loconsole, F Lombardo, M Marzano, A Micali, G Nistic, S Offidani, A Peris, ‡ Pigatto, P Potenza, C Prignano, F Pso-Bio-Covid, ‡ Quaglino, P Rech, G Rongioletti, F Rubegni, P Savoia, P Stingeni, L Talamonti, M Universitario, Policlinico Venturini, M Zalaudek, I
Source	Medline; PMC
abstract	The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is creating an unprecedented global public health emergency with the continuous growth of infected individuals worldwide. Italy was one of the first European country to face the first wave of infection outside mainland China. The first case of COVID-19 was confirmed in Lombardy on February 20th , 2020, and subsequently, a rapid increase in the number of detected cases was observed, spreading through Italy and the rest of Europe.3 As of April 22nd , confirmed COVID-19 cases in Italy were 183,957.
has issue date	2020-08-10(xsd:dateTime)
bibo:doi	10.1111/jdv.16841
bibo:pmid	32735716
has license	no-cc
sha1sum (hex)	d27b50b1bf8356caa6a7f52ef37602c184fb0d46
schema:url	https://doi.org/10.1111/jdv.16841
resource representing a document's title	Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in Italy
has PubMed Central identifier	PMC7436412
has PubMed identifier	32735716
schema:publication	J Eur Acad Dermatol Venereol
resource representing a document's body	covid:d27b50b1bf8356caa6a7f52ef37602c184fb0d46#body_text
is schema:about of	named entity 'COVID-19' named entity 'Letter' named entity 'therapies' named entity 'Management' named entity 'Italy' named entity 'Letter to the Editor' named entity 'SARS-CoV-2' named entity 'infection' named entity 'Novartis' named entity 'Palermo' named entity 'biological agents' named entity 'SARS-CoV' named entity 'dermatological' named entity 'Sandoz' named entity 'Sanofi' named entity 'Sanofi Genzyme' named entity 'Novartis' named entity 'UCB Pharma' named entity 'Celgene' named entity 'biological therapy' named entity 'healthcare providers' named entity 'ixekizumab' named entity 'chronic plaque psoriasis' named entity 'COVID' named entity 'IL-12' named entity 'Sanofi Genzyme' named entity 'Roche' named entity 'UCB Pharma' named entity 'IL-23' named entity 'infection' named entity 'Novartis' named entity 'Novartis' named entity 'Almirall' named entity 'Biogen' named entity 'guselkumab' named entity 'SARS-CoV-2' named entity 'psoriasis' named entity 'COVID-19 pandemic' named entity 'Dermatology' named entity 'Leo Pharma' named entity 'clinical trials' named entity 'medical staff'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software